Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Deficiency of janus kinase-3 causing the near absence of T lymphocytes and Natural killer cells; and normal or elevated B lymphocytes due to an autosomal recessive variant of severe combined immunodeficiency.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for janus kinase-3 deficiency. Research spans Basic Science / Preclinical (75%) and Gene Therapy / Novel Therapeutics (25%).
Jeong PS (2026). [PMID: 40280544](https://pubmed.ncbi.nlm.nih.gov/40280544/). *Journal of advanced research*. [Basic Science / Preclinical]
Li K (2025). [PMID: 40825181](https://pubmed.ncbi.nlm.nih.gov/40825181/). *Chemistry & biodiversity*. [Gene Therapy / Novel Therapeutics]
Wang Z (2024). [PMID: 39506655](https://pubmed.ncbi.nlm.nih.gov/39506655/). *BMC genomics*. [Basic Science / Preclinical]
Liang Y (2024). [PMID: 38625657](https://pubmed.ncbi.nlm.nih.gov/38625657/). *Inflammation research : official journal of the European Histamine Research Society ... [et al.]*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:27 AM UTC